+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Predoctoral Fellowships

Pharmaceutical Research & Manufacturers of America (PhRMA) Foundation

Providing stipend support for graduate students who are engaged in thesis research and have completed most of their pre-thesis requirements

Financial Support

Predoctoral fellowships provide $30,000 per year for 12, 18 or 24 months.

This award is intended solely as a stipend. However, within the yearly award amount of $30,000, up to $1,000 (maximum) per year may be used for incidentals directly associated with thesis research preparation or travel to a scientific conference in the United States.

AI Based Application Success Predictor

1. Scientific Excellence and Innovation

The PhRMA Foundation consistently funds highly innovative research in:

Drug Discovery
Drug Delivery
Translational Medicine
Health Outcomes Research

Successful applications typically propose novel scientific approaches, important biological questions, or innovative therapeutic strategies rather than incremental extensions of existing work.

2. Strong Alignment with Program Priorities

Projects must fit the objectives of the specific funding mechanism.

Examples include:

Drug Discovery → novel therapeutic targets and mechanisms
Drug Delivery → delivery systems, formulations, nanomedicine
Translational Medicine → moving discoveries toward clinical application
VA-HOR → value assessment and health outcomes research

Applications closely aligned with the selected program generally perform best.

3. Translational Potential

A recurring theme across PhRMA Foundation programs is research with a clear pathway toward improving human health.

The Foundation specifically describes its Drug Discovery program as supporting early-stage research with "clear potential for translation to humans." Projects that connect mechanistic science to future therapeutics are particularly competitive.

4. Strong Publication and Presentation Record

Applicant productivity is one of the most visible characteristics of awardees.

Competitive applicants typically demonstrate:

First-author publications
Conference presentations
Strong biosketches
Research accomplishments relative to career stage

Some fellowship programs explicitly require publication records, and sponsor letters are asked to evaluate applicant achievements and scientific progress.

5. Future Leadership Potential

The Foundation repeatedly describes its mission as supporting future scientific leaders.

Award announcements emphasize:

Scientific creativity
Leadership potential
Ability to shape future therapies
Long-term research impact

Applications that demonstrate a strong trajectory toward independent research careers are highly competitive.

6. Strong Mentor and Research Environment

For fellowship mechanisms, the quality of the mentor and training environment is a major factor.

Reviewers assess:

Sponsor commitment
Research infrastructure
Scientific training opportunities
Collaborations and resources

Strong mentorship is particularly important for predoctoral and postdoctoral applicants.

7. Novel Research Questions Addressing Unmet Needs

Recent Foundation communications highlight support for research that addresses:

Unmet clinical needs
New therapeutic opportunities
Emerging treatment modalities
Precision medicine approaches

Projects targeting important unresolved problems are often favored.

8. Evidence of Independence and Skill Development

A notable criterion in several fellowship programs is acquisition of new expertise.

For example, postdoctoral applicants remaining in the same laboratory as their graduate training may receive lower preference because the Foundation values exposure to new research environments and skill development.

9. Communication and Proposal Quality

The application process requires:

Research impact statements
Project abstracts for broad scientific audiences
Letters of support
Detailed research plans

Clear communication and a compelling explanation of scientific impact can substantially improve competitiveness.

10. Potential for Future Funding

The Foundation frequently serves as a launching platform for larger grants.

A survey of former awardees found:

71% later secured NIH funding.
37% later received pharmaceutical industry funding.

Projects that can generate pilot data for future federal, foundation, or industry support align strongly with the Foundation's long-term mission.

Frequently Funded Research Themes

Recent PhRMA Foundation awardees have worked in:

Drug discovery and target identification
Precision medicine
Cancer therapeutics
Gene and cell therapies
Nanomedicine
Drug delivery technologies
Translational medicine
Artificial intelligence in drug development
Pharmacoeconomics
Health outcomes research
Regulatory science and digital health tools

Funding Strategy

A highly competitive PhRMA Foundation application typically includes:

A novel, high-impact scientific question.
Strong alignment with Drug Discovery, Drug Delivery, Translational Medicine, or VA-HOR priorities.
Excellent publication productivity relative to career stage.
A strong mentor and research environment.
Clear translational relevance to improving patient care.
Evidence that the project will develop the applicant into an independent scientific leader.
Potential to generate future NIH, industry, or major foundation funding.

Specialties

Pharmaceuticals

Eligibility Requirements

Applicants (U.S. and non-U.S. citizens) must attend an accredited U.S. university as full-time, in-residence students.
Individuals just beginning graduate school should not apply. Applicants must have completed most of their pre-thesis requirements (at least two years of coursework) and be engaged in thesis research as PhD candidates by the time the award is activated. Award activation can begin as early as January 1, 2027, or as late as August 1, 2027.
Applicants who expect to complete their PhD before December 31, 2027, are ineligible.
Applicants enrolled in MD/PhD programs should not be engaged in required clinical coursework or clerkships while the fellowship is active. Fellows are expected to devote full time (including summers) to their research.
Applicants who have not authored a publication or presented a poster are ineligible.
Applicants currently funded on an institutional training grant (e.g., NIH TL1, T32, T90, or T35 awards or a nonprofit/professional society equivalent) may apply if they state they will forgo the institutional training slot if funded by a PhRMA Foundation predoctoral award.
Applicants are ineligible if they are the recipient of an NIH-F award.

Sponsor Details

Sponsor Institute/Organizations: Pharmaceutical Research & Manufacturers of America (PhRMA) Foundation

Sponsor Type: Corporate/Non-Profit

Address: 670 Maine Avenue SW, Suite 1000 Washington DC, 20024-3556

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity